Cargando…
SPTBN2, a New Biomarker of Lung Adenocarcinoma
OBJECTIVES: The roles played by β-III-spectrin, also known as spectrin beta, non-erythrocytic 2 (SPTBN2), in the occurrence and development of lung adenocarcinoma (LUAD) have not been previously examined. Our study aimed to reveal the relationship between the SPTBN2 expression and LUAD. MATERIALS AN...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563792/ https://www.ncbi.nlm.nih.gov/pubmed/34745988 http://dx.doi.org/10.3389/fonc.2021.754290 |